Navigation Links
DiObex in Medical Technology

DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia

...poglycemia in diabetes patients. The patent grants diobex exclusive rights to methods of reducing the risk o...s. In addition to the recently issued U.S. patent, diobex owns seven U.S. patent applications and 30 corresp...g foreign patent applications relating to DIO-901. diobex also owns or has exclusively licensed seven U.S. p...

DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug

...ditional indications under evaluation for DIO-902, diobex is well positioned to move a strong pipeline of pr...d more effective than racemic ketoconazole. About diobex DiObex, Inc. is a San Francisco-based biotechnolo... products for the treatment of metabolic diseases. diobex has two product candidates in Phase 2 clinical dev...

Diobex Announces Successful Completion of Phase 2a Trial Of DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes

...citing new drug category," commented Daniel Green, diobex President. "DIO-902 offers the possibility of ad..., M.D., Vice President of Development at DiObex. diobex plans on initiating a 16-week phase 2b dose-ranging study with DIO- 902 in mid 2007. About diobex DiObex, Inc. is a San Francisco-based biopharmac...

DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein

...ations normalized during the two week treatment. diobex will conduct a multi-center, 16-week, phase 2b dos...g patients in three countries in mid-2007. About diobex DiObex, Inc. is a San Francisco-based biopharmac... products for the treatment of metabolic diseases. diobex has two products preparing to enter Phase 2b clini...
DiObex in Biological Technology

DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics

...2 is an oral, single enantiomer of ketoconazole, a common anti-fungal drug. diobex is developing DIO-902 as a novel cortisol inhibitor for treating type 2 dia...logy company developing novel products for diabetes and metabolic diseases. diobex has two product candidates in four mid-stage clinical development programs....

DiObex and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release Technology

...ANCISCO and LUND, Sweden, March 18 /PRNewswire/ -- diobex and Camurus announced today that they have signed ...ality of life to coma and death," said David Cory, diobex CEO. "This license agreement and development progr...in-induced hypoglycemia in patients with diabetes. diobex has successfully completed three Phase 1 proof-of-...

DiObex, Inc. to Present at Merrill Lynch Global Healthcare Conference

...te presentation at the upcoming Merrill Lynch & Co, Inc. Global Pharmaceutical, Biotechnology and Medical Device Conference in New York, New York. The diobex presentation will take place on Wednesday, Feb. 6 at 10:20 a.m. at the Grand Hyatt Hotel in the Broadway room. About DiObex DiObex, Inc. is a priv...

DiObex Inc. to Present at BIO Mid-America Venture Forum

...y, September 26th at 1:30 p.m. at the Hyatt Regency Hotel in Room A. About diobex DiObex, Inc. is a San Francisco-based biotechnology company founded to develop novel products for the treatment of metabolic diseases. diobex has two product candidates in Phase 2 clinical development. DIO-901 (very l...
Other Tags
(Date:3/31/2015)... 2015 Clinovo, a leading provider ... Program , the premiere voice of Northern California’s ... science companies. , BayBio brings together the ... innovative and productive life science cluster, helping companies ... humanity’s most pressing challenges. , “We are ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Dr. Russell Ashinoff ... Advanced Reconstruction. He was recently quoted in an Asbury ... by lymphatic issues, causing fluid retention and tissue swelling. ... to relieve and / or improve lymphedema symptoms. ... or alleviate the symptoms of lymphedema. The goal is ...
(Date:3/31/2015)... Dr. Uzma Parvez is having a busy ... conducted Grand Grounds Presentations at St. Michael’s Medical Center for ... Effects”. The event was attended by a large gathering ... positive feedback from the Grand Rounds. It was said ... in a while. , Ahead, Dr. Parvez has been ...
(Date:3/31/2015)... One of the most beautiful and awe-inspiring aspects of a Hawaiian ... big island. The big island of Hawaii, after all, is ... slowly oozing at your feet in one of the most sought ... would never expect to see a live volcano spewing ash and ... until now. , Members of a local and independently owned Gold’s ...
(Date:3/31/2015)... BESLER Consulting today announced the publication ... an Independent Cost Report Review.” , The Medicare ... in the determination of Medicare reimbursement to hospitals ... review, this report can assist management in future ... white paper discusses:,     The anatomy ...
Breaking Medicine News(10 mins):Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3
(Date:3/23/2015)... ANGELES , March 23, 2015  In the ... Federal fraud case conviction losses. This figure accounts for ... which, according to The Nilson Report, exceeds $11 billion ... investigative tool after a crime has occurred. Investor ... and polygraph expert Joe Paolella partnered to ...
(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
Other Contents